No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

The first poster demonstrates proof-of-concept data that Aqtual's therapy selection test can predict treatment response in patients with RA. The second poster provides an interim analysis from ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

Scientists have pinpointed a bacteria, often found in the mouth, which may trigger the painful joint condition.

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

The following is a summary of “MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung ...

Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis (RA) ...